Literature DB >> 22895851

Multivariate versus classical univariate calibration methods for spectrofluorimetric data: application to simultaneous determination of olmesartan medoxamil and amlodipine besylate in their combined dosage form.

Hany W Darwish1, Ahmed H Backeit.   

Abstract

Olmesartan medoxamil (OLM, an angiotensin II receptor blocker) and amlodipine besylate (AML, a dihydropyridine calcium channel blocker), are co-formulated in a single-dose combination for the treatment of hypertensive patients whose blood pressure is not adequately controlled on either component monotherapy. In this work, four multivariate and two univariate calibration methods were applied for simultaneous spectrofluorimetric determination of OLM and AML in their combined pharmaceutical tablets in all ratios approved by FDA. The four multivariate methods are partial least squares (PLS), genetic algorithm PLS (GA-PLS), principal component ANN (PC-ANN) and GA-ANN. The two proposed univariate calibration methods are, direct spectrofluorimetric method for OLM and isoabsorpitive method for determination of total concentration of OLM and AML and hence AML by subtraction. The results showed the superiority of multivariate calibration methods over univariate ones for the analysis of the binary mixture. The optimum assay conditions were established and the proposed multivariate calibration methods were successfully applied for the assay of the two drugs in validation set and combined pharmaceutical tablets with excellent recoveries. No interference was observed from common pharmaceutical additives. The results were favorably compared with those obtained by a reference spectrophotometric method.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895851     DOI: 10.1007/s10895-012-1119-0

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  22 in total

1.  Development and validation of a selective and robust LC-MS/MS method for quantifying amlodipine in human plasma.

Authors:  P Massaroti; L A B Moraes; M A M Marchioretto; N M Cassiano; G Bernasconi; S A Calafatti; F A P Barros; E C Meurer; J Pedrazzoli
Journal:  Anal Bioanal Chem       Date:  2005-05-13       Impact factor: 4.142

2.  Stability indicating LC method for the simultaneous determination of amlodipine and olmesartan in dosage form.

Authors:  K R Patil; V P Rane; J N Sangshetti; R D Yeole; D B Shinde
Journal:  J Chromatogr Sci       Date:  2010-08       Impact factor: 1.618

3.  Simultaneous determination of metoprolol succinate and amlodipine besylate in pharmaceutical dosage form by HPLC.

Authors:  Vaijanath G Dongre; Sweta B Shah; Pravin P Karmuse; Manisha Phadke; Vivek K Jadhav
Journal:  J Pharm Biomed Anal       Date:  2007-11-17       Impact factor: 3.935

4.  Simultaneous estimation of amlodipine besilate and olmesartan medoxomil in pharmaceutical dosage form.

Authors:  S B Wankhede; S B Wadkar; K C Raka; S S Chitlange
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

5.  Simple and rapid HPLC method for determination of amlodipine in human serum with fluorescence detection and its use in pharmacokinetic studies.

Authors:  Gh Bahrami; Sh Mirzaeei
Journal:  J Pharm Biomed Anal       Date:  2004-09-21       Impact factor: 3.935

6.  Validated spectrofluorometric methods for determination of amlodipine besylate in tablets.

Authors:  Hanaa M Abdel-Wadood; Niveen A Mohamed; Ashraf M Mahmoud
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2007-08-11       Impact factor: 4.098

7.  Determination of olmesartan medoxomil in tablets by UV-Vis spectrophotometry.

Authors:  M Celebier; S Altinoz
Journal:  Pharmazie       Date:  2007-06       Impact factor: 1.267

8.  Liquid chromatography-mass spectrometry method for the determination of amlodipine in human plasma and its application in a bioequivalence study.

Authors:  Qiaogen Zou; Ying Zhan; Zhengxiang Ge; Ping Wei; Pingkai Ouyang
Journal:  Arzneimittelforschung       Date:  2009

9.  Determination of amlodipine besylate by adsorptive square-wave anodic stripping voltammetry on glassy carbon electrode in tablets and biological fluids.

Authors:  Azza Abdel Kader Gazy
Journal:  Talanta       Date:  2004-02-27       Impact factor: 6.057

10.  Development of the UV spectrophotometric method of Olmesartan medoxomil in bulk drug and pharmaceutical formulation and stress degradation studies.

Authors:  Jaydeep Patel; Garala Kevin; Anjali Patel; Mihir Raval; Navin Sheth
Journal:  Pharm Methods       Date:  2011-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.